Comparison of total oral bioavailability and the lymphatic transport of halofantrine from three different unsaturated triglycerides in lymph-cannulated conscious rats

European Journal of Pharmaceutical Sciences

Volumn 14, Issue 4, 2001, Pages 331-337

  Holm, René ^a   Müllertz, Anette ^a   Christensen, Egon ^b   Høy, Carl Erik ^b   Kristensen, Henning G ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

Halofantrine; Lipid; Lymphatic transport; Trilinolein; Trilinolenin; Triolein; Unsaturated triglycerides

Indexed keywords

ABSORPTION; BLOOD; STATISTICAL METHODS;

PORTAL ABSORPTIONS;

DRUG DOSAGE;

HALOFANTRINE; TRIACYLGLYCEROL; TRILINOLEIN; TRILINOLENIN; TRIOLEIN; UNCLASSIFIED DRUG;

AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG TRANSPORT; FATTY ACID DESATURATION; LIPOPHILICITY; LYMPH NODE; MALE; MESENTERY LYMPH NODE; NONHUMAN; PRIORITY JOURNAL; RAT; STATISTICAL ANALYSIS;

ADMINISTRATION, ORAL; ANIMALS; ANTIMALARIALS; BIOLOGICAL AVAILABILITY; BIOLOGICAL TRANSPORT, ACTIVE; CATHETERIZATION; CONSCIOUSNESS; FATS, UNSATURATED; LYMPHATIC SYSTEM; MALE; PHENANTHRENES; RATS; RATS, SPRAGUE-DAWLEY; TRIGLYCERIDES;

EID: 0034783589     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0987(01)00186-5     Document Type: Article

References (32)

1. Halofantrine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic potential
2. Effect of short, medium and long chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats
3. Gastric and pancreatic lipase levels during test meal in dogs
4. An experimental system designed to study the in situ intestinal lymphatic transport of lipophilic drugs in anesthetized rats
5. Effect of lipid class and lipid vehicle volume on the intestinal lymphatic transport of DDT
6. Testing potential dosage form strategies for intestinal lymphatic drug transport: Studies in the rat
7. Estimating the maximal potential for intestinal lymphatic transport of lipophilic drug molecules
8. Solubilization and stabilization of an investigational antineoplastic drug (NSC-278214) in an intravenous formulation using an emulsion vehicle
9. Intestinal lymph lipoproteins in rats fed diets enriched in specific fatty acids
10. Lipid based delivery systems for improving the bioavailability and lymphatic transport of a poorly water soluble LTB4 inhibitor
11. Targeted lymphatic transport and modified systemic distribution of CI-976, a lipophilic lipid-regulator drug, via formulation approach
12. Comparison of the lymphatic transport of halofantrine administered in disperse systems containing 3 different unsaturated fatty acids
13. A simplified liquid chromatography assay for the quantitation of halofantrine and desbutylhalofantrine in plasma and identification of a degradation product of desbutylhalofantrine formed under alkaline conditions
14. Intrinsic lymphatic partition rate of mepitiostane, epitiostanol, and oleic acid absorbed from rat intestine
15. Effect of oily vehicles on absorption of mepitiostane by the lymphatic system in rats
16. Lymph chylomicron composition and size are modified by level of intestinal infused cholesterol and triglyceride source in rats
17. A conscious dog model for assessing the absorption, enterocyte-based metabolism and intestinal lymphatic transport of halofantrine
18. Lymphatic uptake of MK-386, a sterol 5α-reductase inhibitor, from aqueous and lipid formulations
19. Difference in the lipoprotein binding profile of halofantrine in fed and fasted human or beagle plasma are dictated by the respective masses of core apolar lipoprotein lipid
20. Factors affecting the lymphatic transport of penclomedine (NSC-338720), a lipophilic cytotoxic drug: Comparison to DDT and hexachlorobenzene
21. Cardiac complications of halofantrine: A prospective study of 20 patients
22. Effect of lipid vehicle on the intestinal lymphatic transport of isotretinoin in rat
23. Lymphatic appearance of DDT in thoracic or mesenteric lymph duct cannulated rats
24. Blood and lymph transport of DDT after oral and parenteral administration to anaesthetised rats
25. DDT absorption and chylomicron transport in rat
26. Lymphatic fatty acid absorption profile during 24 h after administration of triglycerides to rats
27. Lymphatic transport of halofantrine in the triple-cannulated anesthetized rat model: Effect of lipid vehicle dispersion
28. Lymphatic transport of halofantrine in the conscious rat when administered as either the free base or the hydrochlorid salt: Effect of lipid class and lipid vehicle dispersion
29. Uptake of drugs into the intestinal lymphatics after oral administration
30. The lymphatic absorption of p,p-DDT and some structurally-related compounds in the rat
31. Electrocardiographic changes and halofantrine plasma level during acute falciparum malaria
32. Intestinal lymphatic absorption of cyclosporin A following oral administration in an olive oil solution in rats